ENTPD1 and Crohn disease: Increased expression of CD39 upon antisense silencing in T cell subsets derived from Crohn’s disease patients led us to investigate potential therapeutic effects of FANA-CD39-AS oligonucleotides in vivo in a well-characterized mouse model of T cell-mediated colitis28.